Kazia Therapeutics (KZIA) Net Income - Minority (2009)
Kazia Therapeutics (KZIA) posted Net Income - Minority of -$3.9 million for Q2 2009.
Kazia Therapeutics (KZIA) has 1 years of Net Income - Minority data on file, last reported at -$3.9 million in Q2 2009.
- In Q2 2009, Net Income - Minority changed N/A year-over-year to -$3.9 million; the TTM figure through Jun 2009 stood at -$3.9 million (changed N/A YoY), while the FY2009 annual figure was -$3.8 million, changed N/A from the prior year.
- Net Income - Minority held at -$3.9 million in Q2 2009.
- Across five years, Net Income - Minority topped out at -$3.9 million in Q2 2009 and bottomed at -$3.9 million in Q2 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2009 | -3.87 Mn |